MedPage Today August 3, 2024
N. Adam Brown

— But more research and careful regulation is necessary

Looking for an election-year healthcare issue that could bring the two major political parties together? Think there is no such thing?

Think again. A public opinion survey conducted last summer by the University of California, Berkeley, found 61% of U.S. voters support legalizing regulated therapeutic access to psychedelics. Breaking it down by party, liberal voter support for legalized therapeutic access to psychedelics was 80%, compared to moderates at 66%, and conservatives at 45%.

To be clear: Use of psychedelics, such as psilocybin, for recreation is quite different than therapeutic interventions that are paired with intensive psychotherapy. Psilocybin can cause intense psychological experiences, which, if not handled correctly, could lead to adverse...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Provider, Survey / Study, Trends
988 Mental Health Hotline Failed to Boost Service Offerings
Suicide hotline has not led to increased mental health service access: Study
Private Equity Investors Are Still Laser-Focused on Behavioral Health Care
Private Equity in Behavioral Health: Compliance Champions or Cost-Cutting Villains?
Private equity-backed company acquires New York behavioral provider

Share This Article